This study will collect both retrospective and prospective data.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Adult participants with a diagnosis of schizophrenia, as per clinical judgement
Newly prescribed or has initiated treatment with TV-44749 within the past 30 days, in accordance with the approved local label, and decided prior to and independently of participant's study participation
Availability of at least 6 months of retrospective data prior to treatment initiation
Written informed consent from the participant or an authorized representative able to provide written informed consent on behalf of the participant
You may not be if
Established diagnosis of treatment-resistant schizophrenia, including current treatment with clozapine, clozapine treatment within the past 3-months, or treatment-resistant schizophrenia in the opinion of the investigator, as documented in the medical record
Prior non-response to TV-44749 per clinician's judgement
Established current diagnosis of human immunodeficiency virus, cancers, liver failure, kidney failure, neuroleptic malignant syndrome, and diabetic ketoacidosis
The participant has any medical or psychiatric condition that, in the opinion of the investigator, could jeopardize or would compromise the participant's ability to participate in this study
Participation in a clinical trial at the time of enrollment or within previous 6 months
